Abstract: Bronchiectasis, one of the most neglected chronic lung conditions, has a high individual disease burden and economic cost and causes poor quality of life in children/adolescents and adults.

Manage bronchiectasis effectively with these practical lifestyle tips that can help reduce flare-ups, prevent infections, and ...

The dipeptidyl peptidase-1 (DPP1) inhibitor brensocatib became the first licensed therapy for bronchiectasis in the USA and Europe in 2025,1 based on the phase 3 ASPEN trial showing an approximate 20% ...

A chest infection feels like a temporary illness. A few days of coughing, fever, and fatigue, followed by medication, and life returns to normal. But .

This chronic lung condition causes your airways to become permanently widened and scarred. Learn how to spot and treat this ...

Brensocatib, the first FDA-approved medication to treat non-cystic fibrosis bronchiectasis, can reduce symptoms of the ...

In patients with the GPA/MPA subtypes of AAV and comorbid bronchiectasis, standard remission-induction therapy, accompanied by such careful infection-prevention measures as ...

If you have bronchiectasis, the essential goal of treatment is to keep your airway clear. Bronchiectasis is a chronic lung condition in which the airways become widened and damaged, making it harder ...

Chikungunya is spread by mosquito bites and can cause fever, joint pain, and rash. There are no specific medicines to treat chikungunya, so care focuses on relieving symptoms. Preventing mosquito ...